Abortion Clinical Trial
Official title:
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location: A Randomized Pilot Study of Misoprostol Dosing
Patients who seek medication abortion early in pregnancy may have an ultrasound that does not show a pregnancy in the uterus. This is known as a "pregnancy of unknown location". These patients most likely have a pregnancy in the uterus that is too early to be seen on ultrasound, but it is possible that the pregnancy is not seen inside the uterus because it is outside of the uterus, known as an ectopic pregnancy. Patients with ectopic pregnancies are at risk for serious complications, and the medications used for medication abortion may not end an ectopic pregnancy. Currently, at Planned Parenthood League of Massachusetts (PPLM), patients seeking medication abortion, including some patients with a pregnancy of unknown location, are given mifepristone to begin the medication abortion at the clinic and then one dose of misoprostol to take at home to cause the pregnancy to pass. However, research suggests that a second dose of misoprostol leads to a higher rate of completed abortion for certain patients. This research is being conducted to learn if two doses of the at-home misoprostol during the medication abortion process leads to a higher rate of completed abortion for patients with pregnancy of unknown location. In this study, all participants will receive mifepristone as they normally would. Then, participants will be randomly assigned to receive either one dose of misoprostol or two doses of misoprostol.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00884403 -
Gestational Age is Underestimated by Menstrual Dating Compared to Ultrasound Dating in Those Undergoing Abortion up to 20 Weeks
|
||
| Completed |
NCT02083809 -
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
|
N/A | |
| Completed |
NCT00986921 -
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
|
N/A | |
| Completed |
NCT00769912 -
Evaluation of of a Prefixed 50% N2O- 50%O2 Mixture in Legal Abortion Under Local Analgesia
|
Phase 3 | |
| Completed |
NCT00235534 -
Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion
|
N/A | |
| Completed |
NCT06178224 -
Determining Beta-hCG Levels in Patients Through Alternative Sample Types
|
||
| Completed |
NCT04181021 -
Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience
|
N/A | |
| Completed |
NCT01799252 -
Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion
|
N/A | |
| Completed |
NCT00795314 -
Propofol-butorphanol Anesthesia During Uterine Curettage
|
Phase 4 | |
| Completed |
NCT02580175 -
Surgical Evacuation of Abortion Under Ultrasonographic Guide
|
Phase 2 | |
| Enrolling by invitation |
NCT03579550 -
Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus
|
N/A | |
| Completed |
NCT01945385 -
Impact of Video Intervention on Postabortal Uptake of Long Acting Reversible Contraception (LARC)
|
N/A | |
| Terminated |
NCT01436266 -
Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion
|
Phase 3 | |
| Completed |
NCT03227614 -
Friends/Family in the Abortion Procedure Room (FAIR)
|
N/A | |
| Recruiting |
NCT03688581 -
What is the Knowledge and Use of Emergency Contraception
|
||
| Not yet recruiting |
NCT05471895 -
Impact of Sexual Violence on the Incidence of Voluntary Termination of Pregnancy in La Réunion
|
||
| Recruiting |
NCT05688228 -
Voluntary Interruption of Pregnancy on Women's Sexuality
|
||
| Completed |
NCT03136068 -
Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation
|
Phase 4 | |
| Completed |
NCT04651166 -
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
|
Phase 2 | |
| Recruiting |
NCT05645614 -
Anxiety and Pain During Intervention for Abortion Under Local Anesthesia
|